CIK 0001684144
- Non-accelerated filer
- Smaller reporting company
Zomedica Corp.
Sign in to watch- Ticker
- ZOMDF
- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- Alberta, Canada
- Entity type
- Operating
- Phone
- +1 734-369-2555
- Business address
- 1101 TECHNOLOGY DRIVE, SUITE 100, ANN ARBOR, MI, 48108
- Former names
- Zomedica Pharmaceuticals Corp.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2018-05-23 | Williams Rodney James Director | Sale | −12 | $1.95 | $23 | 138,500 |
| 2018-05-22 | Williams Rodney James Director | Sale | −500 | $1.93 | $965 | 139,000 |
| 2018-05-21 | Williams Rodney James Director | Sale | −100 | $2.03 | $203 | 139,900 |
| 2018-05-21 | Williams Rodney James Director | Sale | −400 | $2.00 | $800 | 139,500 |
| 2018-04-20 | Morley Stephanie COO & VP of Product Dev | Exercise or conversion | +104,000 | $0.20 | $21K | 1,459,580 |
| 2018-04-20 | Morley Stephanie COO & VP of Product Dev | Exercise or conversion · Stock Option (right to buy) | −104,000 | 0 | ||
| 2018-03-29 | Morley Stephanie COO & VP of Product Dev | Exercise or conversion | +500,000 | $2.20 | $1.1M | 1,355,580 |
| 2018-03-29 | Morley Stephanie COO & VP of Product Dev | Exercise or conversion · Stock Option (right to buy) | −500,000 | 0 | ||
| 2018-03-29 | Morley Stephanie COO & VP of Product Dev | Exercise or conversion | +500,000 | $0.20 | $100K | 1,355,580 |
| 2018-03-29 | Morley Stephanie COO & VP of Product Dev | Exercise or conversion · Stock Option (right to buy) | −500,000 | 600,000 | ||
| 2018-03-29 | Herbst Bruk Chief Commercial Officer | Exercise or conversion | +62,996 | $2.20 | $139K | 62,996 |
| 2018-03-29 | Herbst Bruk Chief Commercial Officer | Exercise or conversion · Stock Option (right to buy) | −62,996 | 137,004 | ||
| 2018-03-23 | Rowe Jeffrey M Director | Exercise or conversion | +100,000 | $0.20 | $20K | 100,000 |
| 2018-03-23 | Rowe Jeffrey M Director | Exercise or conversion · Stock Option (right to buy) | −100,000 | 0 | ||
| 2018-03-23 | Williams Rodney James Director | Exercise or conversion | +140,000 | $0.20 | $28K | 140,000 |
| 2018-03-23 | Williams Rodney James Director | Exercise or conversion · Stock Option (right to buy) | −140,000 | 0 | ||
| 2018-03-12 | Shameze Rampertab Chief Financial Officer | Exercise or conversion | +176,000 | $0.20 | $35K | 340,000 |
| 2018-03-12 | Shameze Rampertab Chief Financial Officer | Exercise or conversion · Stock Option (right to buy) | −176,000 | 0 | ||
| 2018-01-24 | LeBar James Director | Exercise or conversion | +100,000 | $0.20 | $20K | 220,000 |
| 2018-01-24 | LeBar James Director | Exercise or conversion · Stock Option (right to buy) | −100,000 | 0 |
Page 13 of 14 · 264 trades